scholarly journals Just the Facts: Recommendations on point-of-care ultrasound use and machine infection control during the coronavirus disease 2019 pandemic

CJEM ◽  
2020 ◽  
Vol 22 (4) ◽  
pp. 445-449 ◽  
Author(s):  
Daniel J. Kim ◽  
Tomislav Jelic ◽  
Michael Y. Woo ◽  
Claire Heslop ◽  
Paul Olszynski

The World Health Organization declared the novel coronavirus disease 2019 (COVID-19) to be a pandemic on March 11, 2020, and, currently, there are over 10,000 confirmed cases in Canada, with this number expected to grow exponentially. There has been widespread interest in the use of point-of-care ultrasound (POCUS) in the management of patients with suspected COVID-19. The CAEP Emergency Ultrasound Committee has developed recommendations on the use of POCUS in these patients, with an emphasis on machine infection control measures.

2020 ◽  
Vol 99 (5) ◽  
pp. 481-487 ◽  
Author(s):  
L. Meng ◽  
F. Hua ◽  
Z. Bian

The epidemic of coronavirus disease 2019 (COVID-19), originating in Wuhan, China, has become a major public health challenge for not only China but also countries around the world. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. As of February 26, 2020, COVID-19 has been recognized in 34 countries, with a total of 80,239 laboratory-confirmed cases and 2,700 deaths. Infection control measures are necessary to prevent the virus from further spreading and to help control the epidemic situation. Due to the characteristics of dental settings, the risk of cross infection can be high between patients and dental practitioners. For dental practices and hospitals in areas that are (potentially) affected with COVID-19, strict and effective infection control protocols are urgently needed. This article, based on our experience and relevant guidelines and research, introduces essential knowledge about COVID-19 and nosocomial infection in dental settings and provides recommended management protocols for dental practitioners and students in (potentially) affected areas.


2020 ◽  
Vol 11 (6) ◽  
pp. 9-14
Author(s):  
Ravichandra Ravi ◽  
Srividya Athkuri ◽  
Charishma Chowdary Ponugubati ◽  
Roopesh Borugadda ◽  
Sahithi Pamidimukkala ◽  
...  

Background: The pandemic caused by novel coronavirus (SARS-CoV-2) in Wuhan, China, in December 2019 is a highly infectious disease. The World Health Organization (WHO) has declared the outbreak of Corona Virus Diseases (COVID 19) as a global public health emergency. Currently, research on novel coronaviruses is still in the primary stage. Aims and Objective: The aim of this study is to assess knowledge and awareness on the usage of mouth masks among dental fraternity during this pandemic COVID-19. Materials and Methods: A total of 507 dentists from the Andhra Pradesh (India) region completed a questionnaire-based survey on knowledge, awareness, and infection control measures, such as usage of mouth masks during the pandemic COVID -19. The questionnaire was tailored from the guidance and the information provided for healthcare workers issued by the US Centres for Disease Control and Prevention (CDC). A suitable sampling method was used for the collection of data, and the distribution of responses was presented as percentages. Explanatory statistics were performed for all groups based on the percentage of correct responses. Results: A total of 530 participated in the survey, out of which 507 dentists completely answered the survey, and the response rate was 95.6%. Among the respondents, general practitioners and postgraduates accounted for 58.8% and 41.2%, respectively. There was a statistically significant difference for all the questions solicited among the respondents. General or private practitioners seem to be more aware than postgraduates, as they have answered correctly (>65%) for almost all the questions. Conclusion: The inputs from the study help us to throw some light and fill up space where required. There is a specific and strong need to implement periodic educational programmes and training sessions on infection control practices for COVID-19 among dentists in particular.


2020 ◽  
Vol 258 (5) ◽  
pp. 1049-1055 ◽  
Author(s):  
Tracy H. T. Lai ◽  
Emily W. H. Tang ◽  
Sandy K. Y. Chau ◽  
Kitty S. C. Fung ◽  
Kenneth K. W. Li

2020 ◽  
Vol 148 ◽  
Author(s):  
Chen Ling ◽  
Xianjie Wen

Abstract The outbreak of novel coronavirus pneumonia (coronavirus disease 2019 (COVID-19)), declared as a ‘global pandemic’ by the World Health Organization (WHO), is a public health emergency of international concern (PHEIC). The outbreak in multiple locations shows a trend of accelerating spread around the world. China has taken a series of powerful measures to contain the spread of the novel coronavirus. In response to the COVID-19 pandemic, in addition to actively finding effective treatment drugs and developing vaccines, it is more important to identify the source of infection at the community level as soon as possible to block the transmission path of the virus to prevent the spread of the pandemic. The implementation of grid management in the community and the adoption of precise management and control measures to reduce unnecessary personnel movement can effectively reduce the risk of pandemic spread. This paper mainly describes that the grid management mode can promote the refinement and comprehensiveness of community management. As a management system with potential to improve the governance ability of community affairs, it may be helpful to strengthen the prevention and control of the epidemic in the community.


2020 ◽  
Vol 3 ◽  
pp. 8 ◽  
Author(s):  
Gerald Mboowa

On March 11, 2020 the World Health Organization (WHO) upgraded the status of the coronavirus disease 2019 (COVID-19) outbreak from epidemic to a global pandemic. This infection is caused by a novel coronavirus, SARS-CoV-2. Several rapid diagnostic tests have been developed at an astonishing pace; however, COVID-19 requires more highly specific rapid point-of-care diagnostic tests. This review describes the currently available testing approaches, as well as the available test assays including the Xpert® Xpress SARS-CoV-2 test (takes ~45 min) and Abbott ID COVID-19 test (5 min) as easy to use point-of-care tests for diagnosis of novel COVID-19 that have so far received the US Food and Drug Administration emergency use authorizations clearance. This review is correct as of the date published and will be updated as more diagnostic tests come to light.


Author(s):  
Michael Halim

Since the emergency of the novel coronavirus disease (COVID-19) that is caused by SARS-Cov-2 in 2019, researchers have been on the move to find solutions to mitigate the spread of the virus. Various control measures have been put in place by governments under guidelines and recommendations of key global agencies with the world health organization (WHO) leading in providing information to help fight the pandemic. Multi-agency research efforts have been geared towards developing vaccines for active immunization to prevent COVID-19 infection. This paper is geared towards providing a detailed review and analysis of developments of the current vaccines in terms of safety and efficacy. Approaches that have been taken by different researchers and their findings are the subject of this work. Based on the mechanism by which a vaccine protects an individual against COVID-19 infection, it has been found that the already rolled out vaccines are mRNA (Pfizer and Moderna) and vector (Astrazeneca) vaccine structured. There is also China's Sinovac vaccine which has been in place for the past few years. The four vaccines reviewed here are administered in two doses some days apart. Currently, no vaccine has a safety threat and the efficacies are 95% for COVID-19 mRNA vaccine BNT162b2 (Pfizer), 94.1% for mRNA-1273 vaccine (Moderna), 70.4%forChAdOx1 nCoV-19 vaccine / AZD1222 (AstraZeneca) vaccine and 78% for sinovac respectively. Findings of this paper show that other vaccines are awaiting clinical roll out for trials. Even though these efficacies imply that the vaccines offer significant protection against the infection, further research and evaluation should go on to achieve higher efficacies while addressing any safety concerns that may go beyond local and systemic reactions that occur on patients after vaccination. This study concludes that even with the protection of the present vaccines, individuals must continue wearing personal protective equipment (PPEs) such as masks.


2021 ◽  
pp. 1-2
Author(s):  
Andrea Schulz

<b>Background:</b> The novel coronavirus (COVID-19) pandemic is expected to last for an extended time, making strict safety precautions for office procedures unavoidable. The lockdown is going to be lifted in many areas, and strict guidelines detailing the infection control measures for aesthetic clinics are going to be of particular importance. <b>Methods:</b> A virtual meeting was conducted with the members (n = 12) of the European Academy of Facial Plastic Surgery Focus Group to outline the safety protocol for the nonsurgical facial aesthetic procedures for aesthetic practices in order to protect the clinic staff and the patients from SARS-CoV-2 infection. The data analysis was undertaken by thematic and iterative approach. <b>Results:</b> Consensus guidelines for nonsurgical facial aesthetic procedures based on current knowledge are provided for three levels: precautions before visiting the clinic, precautions during the clinic visit, and precautions after the clinic visit. <b>Conclusions:</b> Sound infection control measures are mandatory for nonsurgical aesthetic practices all around the world. These may vary from country to country, but this logical approach can be customized according to the respective country laws and guidelines.


2021 ◽  
Author(s):  
Surabhi Dixit ◽  
Monal Sharma

In December 2019, an unexpected outbreak was caused by novel corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The lung disease caused by SARS-CoV-2 was given the name of the novel coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on February 11, 2020. Since its origin in the Hubei province of Wuhan city in China, now it has spread to 218 countries worldwide. Panic situation created by COVID-19 has compelled researchers and doctors to work collaboratively. To combat with the disease, every control measures are under consideration from drug discovery to vaccine development. In the management of disease, rapid diagnosis is equally important as development of vaccine and drug. At present, various diagnostic kits are available for COVID-19. With the disease progression, global demand for diagnostics is raising. So, this chapter will include the updates on efficient diagnostic assays and future of diagnostic.


2021 ◽  
Author(s):  
Keda Chen ◽  
Feike Ma ◽  
Ying Wang ◽  
Xinyi Zhuang ◽  
Xuning Zhang ◽  
...  

Abstract The novel coronavirus (COVID-19 or 2019-nCoV) is a respiratory virus that can exist in the mouth and saliva of patients and spreads through aerosol dispersion. In the face of such a serious epidemic, the World Health Organization (who) recommends that governments and individuals take necessary infection control measures. The novel coronavirus (severe acute respiratory syndrome coronavirus; SARS-CoV-2) spread rapidly, causing varying degrees of respiratory disease and, in severe cases. SARS-CoV-2 is a respiratory disease that can be transmitted through direct transmission, aerosol transmission, or contact. Therefore, stomatological hospitals and departments have become high-infection-risk environments. Accordingly, oral disinfectants that can effectively inactivate the virus have become a highly active area of research. Hexadecyl pyridinium chloride, povidone-iodine, and other common oral disinfectants are the natural primary choices for stomatological hospitals. Therefore, this study investigated the inhibitory effect of hexadecyl pyridinium chloride on SARS-CoV-2 in vitro. Vero cells infected with SARS-CoV-2 were used to determine the disinfection effect; the CCK-8 method was used to determine cytotoxicity, and viral load was determined by real-time PCR. The results showed that hexadecyl pyridinium chloride has no obvious cytotoxic effect on Vero cells in the concentration range 0.0125–0.05 mg/mL. The in vitro experiments showed that hexadecyl pyridinium chloride significantly inhibits the virus at concentrations of 0.1 mg/mL or above at 2 min of action. Thus, the results provide experimental support for the use of hexadecyl pyridinium chloride in stomatological hospitals.


2020 ◽  
Vol 5 (2) ◽  
pp. 4
Author(s):  
Siti Munira Yasin ◽  
Kamarulzaman Muzaini ◽  
Ely Zarina Samsudin ◽  
Mohamad Ikhsan Selamat ◽  
Zaliha Ismail

The outbreak of novel coronavirus disease 2019 (COVID-19) has been declared a Public Health Emergency of International Concern by the World Health Organization. The incidence of this pandemic continues to rise, with 40,665,438 confirmed cases and 1,121,843 deaths worldwide by 21 October 2020. During this public health crisis, healthcare workers are at the frontline of the COVID-19 outbreak response, and as such are at risk of being infected and developing job burnout while in the line of duty. This study reviews the history of COVID-19 outbreak, infection control measures in hospitals during COVID-19 outbreak, healthcare workers’ risk of infection and other health effects from battling COVID-19, and challenges and recommendations for protecting healthcare workers during this pandemic. At present, healthcare workers are every country’s most valuable resources, and their safety must thus be ensured. Strong medical leadership, clear pandemic planning, policies and protocols, continuous educational training, adequate provision of personal protective equipment, psychological support, and the provision of food, rest, and family support for healthcare workers would augment a climate of safety in the workplace, ensure their wellbeing, and improve their capacity to battle this ongoing pandemic.


Sign in / Sign up

Export Citation Format

Share Document